Functional Restoration and Integrative Therapies in Service Members With Neuromusculoskeletal Injury
Determinants of the Optimal Dose and Sequence of Functional Restoration and Integrative Therapies in Service Members With Neuromusculoskeletal Injury
A tanulmány áttekintése
Állapot
Körülmények
Részletes leírás
Objectives and Rationale. Pain due to neuromusculoskeletal injuries is a leading cause of disability among active duty military Service members. The injury rate is significant with 628 neuromusculoskeletal injuries per 1000 person-years among active duty military Service members. Neuromusculoskeletal injuries include amputations following battlefield trauma, repetitive motion injuries related to equipment use or weight-bearing postures, and even injuries or strains incurred during off-duty pursuits. Regardless of cause, the effects on both individual Service members and military readiness are significant: Only 13% of Service members being treated primarily for pain ever return to the field.
The Department of Defense (DoD) has recently expanded its capacity to provide both functional restoration (FR) and complementary and integrative medicine (CIM) therapies for neuromusculoskeletal injury, pain, and disability. The proposed research aims to determine the most effective treatment combination, sequence, and duration of standard rehabilitative care (SRC), such as physical and occupational therapy in combination with cognitive behavioral therapy and CIM therapies, such as acupuncture and chiropractic, for Service members preparing to enroll in an intensive FR program that is currently the DoD-recommended treatment. In addition, this study aims to identify ways to predict in advance which patients will respond best to which therapeutic regimens.
Potential Impact. This research has the potential to determine which patients are most likely to benefit from the non-medication pain therapies currently available in all Army Interdisciplinary Pain Management Centers (IPMC) and how these therapies can most effectively be combined to achieve the greatest improvements in pain impact, quality of life and ability to return to duty following injury.
Patients Who Will Benefit. This study will involve active duty Service members referred to an Army IPMC. The results will be shared with other Military Health System (MHS) and Veterans Health Administration (VHA) pain management centers so that active duty Service members and veterans across United States may benefit from a treatment approach that is tailored to their individual characteristics. It is anticipated that the knowledge gained through this research will be applicable to family members of Service members and veterans and will ultimately lead to expansion of TRICARE benefits to include CIM therapies.
Potential Clinical Applications, Benefits, and Risks. This research will assist providers in determining when to refer their patients with neuromusculoskeletal pain for SRC and/or CIM therapies prior to FR. It will assist IPMCs in developing treatment plans tailored to the needs of each patient. Service members and veterans will benefit by being referred for these approaches when appropriate during the course of disabling chronic pain conditions. Ultimately, it is hoped that decision tools can be imbedded in the electronic medical record to guide health care providers to consider referral for these therapies in patients who may benefit. This study will advance our ability to effectively tailor therapies for rehabilitation from neuromusculoskeletal pain for different patients to yield the greatest benefit in physical function and quality of life. The risks of these interventions are minimal; Service members may experience general muscle soreness for the first week or so of increased physical activity, but this typically resolves.
Projected Timeline. This research will determine the optimal combination, sequence, and duration of therapies. It is expected that some active duty Service members could see improvements in function and quality of life within three weeks, but others may require up to six weeks to experience meaningful improvement.
Benefit to Military Personnel. This research will benefit Service members experiencing pain due to neuromusculoskeletal injury. It will identify ways to direct them to the therapies most likely to yield meaningful improvements in function and quality of life, and thus facilitate their return to duty. The recommendations from this study will be shared with pain management centers throughout the DoD, VHA; and, we hope, eventually to TRICARE members.
Tanulmány típusa
Beiratkozás (Várható)
Fázis
- Nem alkalmazható
Kapcsolatok és helyek
Tanulmányi helyek
-
-
Washington
-
Tacoma, Washington, Egyesült Államok, 98431
- Madigan Army Medical Center
-
-
Részvételi kritériumok
Jogosultsági kritériumok
Tanulmányozható életkorok
Egészséges önkénteseket fogad
Tanulmányozható nemek
Leírás
Inclusion Criteria:
- Active duty service members
- Neuromusculoskeletal or neuropathic pain ≥ 3-months duration
- Pain of sufficient severity to bring about dysfunction in daily social, vocational, and/or interpersonal activities
Exclusion Criteria:
- Major surgeries within past 6 months or planned within next 6 months
- Unstable psychological disorders
- Active substance use disorder
Tanulási terv
Hogyan készül a tanulmány?
Tervezési részletek
- Elsődleges cél: Kezelés
- Kiosztás: Véletlenszerűsített
- Beavatkozó modell: Szekvenciális hozzárendelés
- Maszkolás: Nincs (Open Label)
Fegyverek és beavatkozások
Résztvevő csoport / kar |
Beavatkozás / kezelés |
|---|---|
|
Kísérleti: Complementary and Integrative Therapies
Chiropractic, Acupuncture, Yoga, Biofeedback (if indicated), and Foam roller instruction
|
Intervention time period is 3 - 6 weeks.
|
|
Aktív összehasonlító: Standard Rehabilitative Care
Cognitive Behavioral Therapy (CBT) 60-minute orientation, CBT psychoeducation group, and Physical therapy/occupational therapy
|
Intervention time period is 3 - 6 weeks.
|
Mit mér a tanulmány?
Elsődleges eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
Change from Baseline Pain Intensity
Időkeret: 3 months
|
Pain Intensity 10-pt Numeric Rating Scale
|
3 months
|
|
Change from Baseline Pain Impact
Időkeret: 3 months
|
Aggregate score calculated from Defense and Veterans Pain Rating Scale (DVPRS)
|
3 months
|
Másodlagos eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
Depression
Időkeret: baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
Patient Reported Outcome Measurement Information System
|
baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
|
Anxiety
Időkeret: baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
Patient Reported Outcome Measurement Information System
|
baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
|
Emotional Distress - Anger
Időkeret: baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
Patient Reported Outcome Measurement Information System
|
baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
|
Sleep Disturbance
Időkeret: baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
Patient Reported Outcome Measurement Information System
|
baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
|
Fatigue
Időkeret: baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
Patient Reported Outcome Measurement Information System
|
baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
|
PTSD
Időkeret: baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
Primary Care PTSD Screen
|
baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
|
Patient Activation Measure
Időkeret: baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
A 22-item survey that addresses four stages of patient activation: (1) believing the patient role is important, (2) having the confidence and knowledge necessary to take action, (3) actually taking action to maintain and improve one's health, and (4) staying the course even under stress.
Patients are asked to agree or not to agree with each of the 22 items.
|
baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
|
Drug Use
Időkeret: baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
Drug Use Questionnaire
|
baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
|
Pain Catastrophizing
Időkeret: baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
Pain Catastrophizing Scale
|
baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
|
Kinesiophobia
Időkeret: baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
Tampa Scale for Kinesiophobia
|
baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
|
Pain Self-Efficacy
Időkeret: baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
Pain Self Efficacy Questionnaire
|
baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
|
Chronic Pain Acceptance
Időkeret: baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
Chronic Pain Acceptance Questionnaire
|
baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
|
Functional Capacity
Időkeret: baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
Roland-Morris Disability Questionnaire and Canadian Occupational Performance Measure
|
baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
|
Opioid Utilization
Időkeret: baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
Opioid Utilization Screener
|
baseline, 3 weeks, 6 weeks, 9 weeks, 3 months, 6 months
|
|
Cortisol
Időkeret: baseline, 6 weeks
|
Salivary Cortisol
|
baseline, 6 weeks
|
|
Oxidative Stress
Időkeret: baseline, 6 weeks
|
Urine Sample
|
baseline, 6 weeks
|
|
Genomic DNA
Időkeret: baseline
|
Buccal Sample
|
baseline
|
|
Army Physical Fitness Test (APFT)
Időkeret: baseline, 6 weeks, 3 months, 6 months
|
Passing scores of 60 on all 3 components (push-ups, sit-ups, 2-mile run) of the APFT will be operationalized as "force-readiness".
|
baseline, 6 weeks, 3 months, 6 months
|
Együttműködők és nyomozók
Szponzor
Együttműködők
Nyomozók
- Kutatásvezető: Ardith Z Doorenbos, RN, PhD, University of Washington
Tanulmányi rekorddátumok
Tanulmány főbb dátumok
Tanulmány kezdete (Tényleges)
Elsődleges befejezés (Várható)
A tanulmány befejezése (Várható)
Tanulmányi regisztráció dátumai
Először benyújtva
Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak
Első közzététel (Tényleges)
Tanulmányi rekordok frissítései
Utolsó frissítés közzétéve (Tényleges)
Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak
Utolsó ellenőrzés
Több információ
A tanulmányhoz kapcsolódó kifejezések
Kulcsszavak
További vonatkozó MeSH feltételek
Egyéb vizsgálati azonosító számok
- STUDY00004220
Gyógyszer- és eszközinformációk, tanulmányi dokumentumok
Egy amerikai FDA által szabályozott gyógyszerkészítményt tanulmányoz
Egy amerikai FDA által szabályozott eszközterméket tanulmányoz
Ezt az információt közvetlenül a clinicaltrials.gov webhelyről szereztük be, változtatás nélkül. Ha bármilyen kérése van vizsgálati adatainak módosítására, eltávolítására vagy frissítésére, kérjük, írjon a következő címre: register@clinicaltrials.gov. Amint a változás bevezetésre kerül a clinicaltrials.gov oldalon, ez a webhelyünkön is automatikusan frissül. .
Klinikai vizsgálatok a Krónikus fájdalom
-
Xijing HospitalBefejezveAorta disszekció | AKI - Akut vesekárosodás | PAI-1 4G/5G polimorfizmusKína